Bausch Health Companies Inc. is a Specialty Pharmaceuticals & Health Care company headquartered in Laval, Quebec, Canada. In FY2025, it reported $10.3B in revenue and $157M in net income. It had about 20,300 employees and is led by Thomas J. Appio.
How Bausch Health Makes Money
Bausch Health makes money through gastroenterology, dermatology, international pharmaceuticals, aesthetics, diversified products, and the consolidated Bausch + Lomb eye-care business. Its customers include patients, physicians, hospitals, pharmacies, distributors, eye-care professionals, and international health systems. The business model depends on scale, risk selection, customer relationships, distribution, technology, and disciplined capital allocation.
Bausch Health Strategy
Bausch Health is focused on Salix gastroenterology, international pharmaceuticals, Solta Medical aesthetics, Bausch + Lomb performance, debt refinancing, and operational execution. The main risks are bausch health remains exposed to leverage, refinancing needs, patent and generic competition, product concentration, regulatory risk, and the strategic complexity around bausch + lomb. The profile was refreshed on 2026-07-21 from annual-report, earnings-release, and regulatory sources.
